C-Q13OLeucadia Therapeutics
outpatient treatment, diagnostics, CT scan
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-Q13O
C-Q13OC-Q13Ooutpatient treatment, diagnostics, CT scan
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Encinitas Now | > Spotted on April Fools but we’re not fooling
Encinitas Now | > 🌈 Thank You for Celebrating with Us at Leucadia Pride
Leucadia National Corporation - Page 6 - The New York Times Skip to content Skip to site index Leucadia National Corporation Today’s Paper Supported by SKIP ADVERTISEMENT Business Leucadia National Corporation Latest Search Search Clear this text input Morning Agenda: Jefferies, Small and Emboldened The investment bank took federal bailout money and is not hemmed in by the restrictions imposed on banks that did. By Amie Tsang Jefferies Reports $166.7 Million Loss in Quarter “We are humbled,” Richard Handler, the investment bank’s chief executive, said of the quarter, which was hurt by rocky ma … en DealBook Richard Handler of Leucadia to Join Board of Ex-SAC Executive’s New Fund Richard Handler is joining the board of Folger Hill Asset Management, which was started by Solomon Kumin and Leucadia National. By William Alden DealBook Ex-SAC Executive, Solomon Kumin, Strikes Out on His Own A former top executive for Steven A. Cohen is testing whether a person needs experience as a trader to raise big dollars for a hedge fund. By Matthew Goldstein DealBook Handler, Leucadi … binger The share sale is the latest in a series of moves by the embattled hedge fund billionaire Philip A. Falcone to focus on the Harbinger Group after reaching an $18 million settlement with the S.E.C. By Alexandra Stevenson The 30-Minute Interview Hugh R. Frater Mr. Frater is the chief executive of Berkadia Commercial Mortgage, a joint venture of Berkshire Hathaway and the Leucadia National Corporation. By Vivian Marino DealBook Chief of the Jefferies Group Earned $19 Mill … vestment trust as it prepares to take ownership of Rockefeller Center. Gotham's proposal, which has the support of several of the trust's other large shareholders, would use a rights offering to raise at least $105 million and combine that with a senior loan of at least $350 million to replace some of the trust's high-cost debt and give it the financial wherewithal to operate the property. By Stephanie Strom Block to Rockefeller Center Deal Is Seen A sufficient number of shar
Highlights From Past Leucadia Shareholder Letters and Link to Current Important Message – Fraud Alert / Alerta de Fraude / Alerte à la Fraude We have been made aware of bad actors holding themselves out as Jefferies representatives targeting individuals around the world. More Info Important Message – Fraud Alert / Alerta de Fraude / Alerte à la Fraude Jefferies has recently learned that unknown persons are using the Jefferies name and the names and photographs of Jefferies employees, without authorization, to offer investment clubs or other investments or employment to individuals around the w … rket Disclosure Giving Back Giving Back Focus & Commitment Jefferies Family Scholarship Global Trading Days GoodToday Conferences & Events Conferences & Events Upcoming Events Past Events Careers Careers Careers Nothing is more important to Jefferies than our human capital. It’s why we prioritize recruiting, supporting, training and developing our employee-partners. Overview Experienced Professionals Experienced Professionals Advance Your Career Explore Opportunit … Explore Opportunities Campus Events Explore Mentorships Benefits & Programs Apply Now Apply Now Intern and Entry-Level Programs All Other Opportunities Investor Relations Investor Relations Investor Relations Access company financials, governance documents, shareholder resources, press releases and more. Sign up for investor email alerts to stay informed. Overview Leadership & Governance Leadership & Governance Jefferies Leadership Board Committees Governance Docu … esident of Leucadia and one of us assumed the role of Chairman and the other is rolling up his sleeves to start again, this time with family as his partners. The rationale for the acquisition and the succession plan were spelled out in the proxy statement sent to you prior to the Shareholders Meeting at which 81% of our shareholders voted, with over 99% in favor. We are gratified with that vote of confidence. Leucadia usually flies below the radar and is often unconventional … fit.” In 2000, Leucadia invested $100 million in Jefferies Partners Opportunity Fund and for seven years earned a 20% return after fees. A second fund, Jefferies High Yield Trading, was launched in 2007 at the top of the market. Despite the impossible timing and the catastrophic financial environment, we eked out a reasonable return on that fund
%PDF-1.6 %���� 5345 0 obj > endobj 5371 0 obj >/Filter/FlateDecode/ID[ ]/Index[5345 51]/Info 5344 0 R/Length 120/Prev 2786627/Root 5346 0 R/Size 5396/Type/XRef/W[1 3 1]>>stream h�bbd```b`� "�@$S�du�����`� ��&w��G��m@R�O,� &��H0� f���`39��H� �-���}`�j`�/A$� ���#�HX ����i�0(�w endstream endobj startxref 0 %%EOF 5395 0 obj >stream h��V�OSW?�� ��/��U�"�A%�l �ߒ�d j��Њ_2[T�h*����-k_58eq�- U�� f���5��AQ(~�"�lj��l��WJ����e��{��|��s������ @P���g�A���j��2WX�~���� E�� �rrr=Z�"���τ ��Dl�,�� KC�fT�Hl�)% 1lJ}Jw��߂�k��H�����]ό��U�\�5j (vz�E����h�q��nS�6��i�S�.[ … _߹�+������,�|uw�Sݥ����.�K��wk_�hj��V�K��o�� endstream endobj 139 0 obj >stream application/postscript Print Adobe Illustrator CS3 2010-03-04T09:35:28-05:00 2011-03-03T06:00:12-05:00 2011-03-03T06:00:12-05:00 256 156 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK
DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f
Hx8fHx8fHx8fHx8 … 3D0A4611DEA7C0E5A02B561637 uuid:33E70D45EAB611DCBB2DBB3ADB600C28 converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to … t to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator Print 51.000000 66.000000 Picas 1 False False Helvetica-Bold Helvetica Bold Type 1 001.007 False HelveBol; Helvetica Bold Black Default Swatch Group 0 White CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Black CMYK … .31r1 2015-03-11T20:43:06-04:00 2015-03-11T20:43:06-04:00 QuarkXPress(R) 9.31r1 application/pdf Frontline03_Cover %%DocumentCustomColors: (PANTONE 1817 C)
%%+ (PANTONE 400 C)
%%+ (PANTONE 408 C)
%%DocumentProcessColors: Black
%%CMYKCustomColor: .466 .817 .735 .406 (PANTONE 1817 C)
%%+ .239 .206 .262 .002 (PANTONE 400 C)
%%
S-8 POS 1 c72889_s8pos.htm As filed with the Securities and Exchange Commission on March 1, 2013 Registration No. 333 -185318 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-4 ON FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________ LEUCADIA NATIONAL CORPORATION (Exact name of registrant as specified in its charter) New York (State or other jurisdiction of incorporati … ration Statement; Provided, however , that paragraphs (1)(i) and (1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed by Leucadia pursuant to Sections 13 or 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement; (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a … he opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. II-3 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the undersigned registrant certifies that it has reasonable grounds to believe that it meets all of the requ
Our Story | Vigilucci's Restaurants Home Locations Cucina Italiana Trattoria Italiana Seafood & Steakhouse Vigilucci's Market Lunch & To-Go Catering Group Dining Cucina Italiana Trattoria Italiana Seafood & Steakhouse Gift Cards Loyalty Cards Contact CLOSE MENU The Vigilucci's Story Our Story Restaurateur Roberto Vigilucci is passionate about food. The Carlsbad resident hails from Milano, Italy, where families are raised in the kitchen, and food is a centerpiece of the culture. Upon visiting the U.S. in the mid-1980s, Roberto fell in love with San Diego and decided t … tate Street in the Carlsbad Village. The Cucina’s authentic Italian cuisine and award-winning wine list provide a unique and memorable escape to the flavors of the Tuscan countryside. Vigilucci’s Seafood & Steakhouse opened in 2002 on the corner of Tamarack and Pacific Coast Highway featuring only certified prime steaks and the freshest seafood with an Italian flair, topped by 180-degree ocean and sunset views, the restaurant offers true dining excellence in North County
Leucadia National Corporation, Annual Reports from the Years, 1978-2012 Indigo Award winner 2024 / Submissions are now open Submit Your Work Indigo Design Award Winners Congratulations to Indigo Awards winners 2026 2025 2024 2023 2022 2021 2020 2019 2018 View the Shortlisted winners Select your expertise: by Loading... Winner Created by: Credits Printing: Marta Conti, Lucia Conti, Roberto Conti at Conti Tipocolor Share: facebook twitter back to all winners view more winners INDIGO Enter your email to subscribe to our newsletter Subscribe legal terms contact us FAQs Rua Andre Brun 7 Apt RCD 135
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Skip to main content Ratings Sectors Insights Events Subscriptions About Us Contact Us About About Us Contact Us Careers Media Relations Feedback Regulatory Regulatory Affairs Criteria Code of Conduct & Ethics Privacy Policy Report an Issue / Whistleblowing Product Rating Actions Coverage Research & Analytics Products & Tools Rating Performance Region Europe North America Africa Asia Latin America Middle East Fitch Group Fitch Group Fitch Ratings Fitch Solutions Fitch Bohua Fitch Learning Owned by Hearst Copyright © 2026 Fitch Ratings, Inc., Fitch Solutions, Inc. and their subsidia
MedTech World - Know who you’ll meet on the Expo Floor at... Facebook Log In MedTech World's Post MedTech World February 3 · Shared with Public Know who you’ll meet on the Expo Floor at #MTWMiddleEast | Dubai 2026 Connect with MedTech startups and industry experts from 12–13 February in Dubai. Startup Village, Supported by Ascend Clinical Meet innovators including ZERObrush, Imagine Devices Inc., Opportunity Health S.L., Sinaptica Therapeutics, Allotex, Electroducer, Sub-Q Bionics, Komed Health AG, SurgeOmniQ-X, Calla Lily Clinical Care, Leucadia Therapeutics and more, with founders on-si
News - Leucadia Asset Management Asset Managers Investors Investment Offerings Management Team News Insights Contact Us In The News December 2025 Jefferies to Acquire 50% Interest in Hildene Holding Company, Expanding Strategic Relationship that Began in 2022 – Read More – : Jefferies to Acquire 50% Interest in Hildene Holding Company, Expanding Strategic Relationship that Began in 2022 August 2025 Partners Capital Investment Group Announces Transfer of Managed Account Platform to Subsidiary, Establishes Strategic Relationship with Leucadia Asset Management – Read More – … unces Strategic Relationship with Manteio Capital May 2021 Topwater Hard Closes Fund After Investment From Top Five Endowment – Read More – : Topwater Hard Closes Fund After Investment From Top Five Endowment April 2021 Jefferies Finance Announces Expansion of Asset Management Capital Raising Efforts – Read More – : Jefferies Finance Announces Expansion of Asset Management Capital Raising Efforts September 2020 Leucadia Asset Management Announces Strat
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.4 %�쏢 5 0 obj > stream x���ɋ%�q��bi\2���^Ǫ�.��\��A�����O�� �3����/^�@`͡�~�/322�\��{.o�=�����O��j=����{c�gj�=�+�z�OOc�����OO|��/��}������S}����c?�"�Cy,�����Lܕ'sU&��Gy0[?���i̤\��ra��o�U���v ��]�� �� �xt\Y���˺l�S�bk����]�縵���]*���l���2�����X���e-��o,����.��I�i �NL�w��+�T�Q��N�� t��ڳ ����W�;�Yu,���c��W�?�Y���kE�Kؚܾ�X�֑�/��d9͖&�i��v2��L��E���]�ໜ�u����G>��a�Z�����>g��)d�3٦�$�-�ע���P:�F!Ĝb1��\��[�>I����/T�_�a��~W���wg��b�$Đ����ū��� �S�8�x���BJ�gC��� � � ���c�q�^����\Ц�Ą>��T.�l�SrZ!��G�\�)rm}��=����vl3�I�l+`+��3[�c;�#B��-���%B�Y;B�1���r̖8� ��)mz��cv�E�1;����:��\� K�b
%PDF-1.6 %���� 69 0 obj >stream h�� �0�_��k������"���C� ]LiZз���dɐ;�/��q�( e�.a�JR�T� ��u�19�a�BU��?F� ��G� ����Yn؎OAGc9^��ݺ�g���4{�FG�4\]@^�� ��A�ӫw|���� @'�q*��q� ���M��$[B���-���L�dĮ���Z�˛a�]��eJ�_�t�8��~ 0�Jd endstream endobj 70 0 obj >stream hޜѽ �@�W�7�����*�T��B%(B H � � ��\��|͐��(XB9 VЅkK`b�DU%��5N�!�?tw!*����}�}7�D��š����/�n5��Y ��gw�����n�y�C�H���O��t�IS�V M:�� �D�2i��9�6��Č�� /�}�$�% endstream endobj 71 0 obj >stream h��M �0���. ��I&�RhAq�ຶA%Zoot�ʕ���� � ��`r�ڂ >stream 2017-09-14T10:57:35-04:00 RICOH MP C2503 2017-09-14T11:29:09-07:00 … 00 2017-09-14T11:29:09-07:00 Adobe Acrobat Standard DC 15 Paper Capture Plug-in application/pdf uuid:89cfb0c0-62b4-4c98-adc4-bbd88e7f6605 uuid:5c91391a-ac95-4c99-b1b3-e68b485b8b3f endstream endobj 27 0 obj > endobj 29 0 obj > endobj 55 0 obj >stream H��W�n�H}�������{����xd1{C �e�M�l$R�%��o5eKUT�28��Gu?u�k��$� �RJ5�R��w��2�m���W_������� �������*�6ό�������z�y� �ܭW&��֫w e����z�W)�q�]�^�&ה~B�,'l��� �"�1��#��J� 6�=�tVЗ���g 2ϵS A��h� {���B�@A��M�g�49�
Exhibitor List- 2018 NPPA Conference | NPPA: National Pharmacy Purchasing Association Home Attendee Conference Info Attendee Reg & Info Hotel Reservations Info CE & Events Schedule Call for Speakers Photos of Conference Scholarship Program 340B University Event More Conference Info Exhibitor Conference Info Exhibitor/Sponsor Info Schedule of Events Paris LV Hotel Reservations & Info Horseshoe LV Hotel Reservations & Info Check-In & Booth Info List of Exhibitors More Conference Info Membership Drug Product News Join NPPA Benefits for Members Outstanding Buyer of the Yea … Drug Product News Join NPPA Benefits for Members Outstanding Buyer of the Year Award Reward Programs Other Member Resources Advertising Banner Ads for Conf. Attendee Reg pages Website Banner Advertising Vendor eBlast Advertising RxBuyer eNews Advertising Resources Jobs Search/Postings Record Your CE’s About About NPPA Contact Contact Us Select Page Exhibitor List – 22nd Annual 2018 NPPA Conference, August 21-23 Exhibitor List, 2018 NPPA Conference – as of … Dr. Reddy’s Laboratories, Inc. Lanyards Sponsor Outstanding Buyer of Year Award Sponsor Exela Pharma Sciences, LLC Fagron Sterile Services/JCB Laboratories FFF Enterprises Fresenius Kabi USA, LLC Tote Bags Sponsor Gensco Pharma Geritrex Grifols USA, LLC Guaranteed Returns Gulf Coast Pharmaceuticals Plus, LLC HealthTrust Health Care Logistics Heritage Pharmaceuticals Hikma Pharmaceuticals USA, Inc. (formerly West-Ward Pharmaceuticals, Inc.) Inmar International Medical In … m Services, LLC Pinnacle 1 Inventory Piramal Critical Care Precision Dose, Inc. Scholarship Program Sponsor Prodigy Health Quality Inventory Services QuVa Pharma, Inc. Rees Scientific Reliance Wholesale, Inc. Scholarship Program Sponsor Ritedose Pharmaceuticals, LLC RxSystems, Inc. Safe Chain Solutions, LLC Sagent Pharmaceuticals Program Binder Sponsor Sandoz SCA Pharmaceuticals Shire Sky Packaging Sun Pharma Sunstar Americas, Inc. Teva Pharmaceuticals The Standard Distributo … Inc. Tri-Pharma Unit Dose Solutions Upsher-Smith Laboratories, LLC US WorldMeds Scholarship Program Sponsor VaxServe Veltek Associates, Inc. Virtus Pharmaceuticals VistaPharm, Inc. Waste Management PharmEcology West-Ward Pharmaceuticals (now Hikma Pharmaceuticals USA, Inc.) WG Critical Care Winfield Laboratories Wockhardt USA LLC X-GEN Pharmaceut
Carlsbad-Oceanside-Vista and Del Mar-Leucadia Jointly Sponsor an Election Information Event - AAUW California Skip to content AAUW California Business Branch Tools AAUW Fund Projects/Programs Calendar Directory Help? Facebook Instagram Linkedin YouTube Home About Us Join Us Support Us Public Policy Tech Trek Contact Us Search Search Search Search Toggle Menu Carlsbad-Oceanside-Vista and Del Mar-Leucadia Jointly Sponsor an Election Information Event Home / Public Policy / Public Policy-Branch Events / Carlsbad-Oceanside-Vista and Del Mar-Leucadia Jointly Sponsor an Election Information Event Up … s Support Us Public Policy Tech Trek AAUW California Business Branch Tools AAUW Fund Directory Calendar Help Toggle Menu Close Search for: Search
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
424B3 1 c71828_424b3.htm 3B2 EDGAR HTML -- c71828_preflight.htm Pursuant to Rule 424(b)(3) Registration No. 333-185318 JOINT PROXY STATEMENT/PROSPECTUS PROPOSED MERGER–YOUR VOTE IS IMPORTANT We are very pleased to provide this document to you. It is a prospectus related to a proposed issuance by Leucadia National Corporation (referred to as “Leucadia”), of its common shares pursuant to an Agreement and Plan of Merger (referred to as the “second merger agreement”) entered into by, among others, Leucadia and Jefferies Group, Inc. (referred to … ng of shareholders, Leucadia shareholders will vote on, among other things, the proposal to issue Leucadia common shares and the proposal to amend Leucadia’s certificate of incorporation with respect to its existing transfer restrictions. At Jefferies’ special meeting of stockholders, Jefferies stockholders will vote on, among other things, the proposal to adopt the first merger agreement and to approve the transactions contemplated by the first merger agreement, wh … ia. In order to avert the possibility that the transactions could result in the application of tax law limitations on the use of certain of Leucadia’s tax attributes, the second merger agreement limits the amount of Leucadia common shares that can be issued to certain persons (other than direct or indirect subsidiaries of Leucadia) if such issuance would otherwise cause a person or group of persons to become a 5% shareholder or own 5% or more of the combined Leucadia com … tors unanimously recommends that Leucadia shareholders vote “FOR” the proposal to approve the Leucadia share issuance; “FOR” the proposal to approve the charter amendment; “FOR” the approval on an advisory (non-binding) basis of the compensation that may be paid or become payable to Leucadia’s named executive officers that is based on or otherwise relates to the proposed transactions; and “FOR” the proposal to adjourn the Leucadia … onsider and vote on the following proposals: • Proposal 1: to consider and vote upon a proposal to adopt the Agreement and Plan of Merger, dated November 11, 2012 (as it may be amended from time to time, referred to as “first merger agreement”), by and among Jefferies, New Jefferies and Merger Sub One an
Leucadia bolsters trade finance asset management offering with senior hire | Global Trade Review (GTR) Leucadia bolsters trade finance asset management offering with senior hire | Global Trade Review (GTR) --> .col --> News Global Africa Americas Asia Europe Mena Digital Trade Sustainability Features Events GTR Events Partner Events People On the Move GTR Trade Leaders Multimedia Videos Podcasts Sponsored Content Publications Awards GTR Awards GTR+ MEA Awards The BExA-GTR Young Exporter Awards 2026 Directory Subscribe Search News Global Africa Americas Asia Europe Mena Digital Trade Sustainabi
Bicycle Therapeutics–Leucadia: investor conference, 202311 supply service Bicycle Tx at Jefferies 2023 London Healthcare Conference - [LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal Zum Inhalt News People Events Deals Organisations Newsletter About us Contact Top News Merck KGaA to Acquire Bio-Techne for $11.3b (€9.9b) Merck Announces Healthcare Leadership Changes RQ Biotechnology Closes $115m (£85.5m) Series A Financing Tecan Integrates Nvidia’s Agentic AI into Lab Platform Nvidia Announces BioNeMo Agent Toolkit at BIO 2026 Merck Partners with Versant Ventures to Launch … rapeutics Raises $5m Investment Led by Daphni Kos Biotechnology Partners: First Fund Reaches $123m Caszyme: WiFIX Consortium Awarded €1m Eurostars Grant AMD, Dell & Univ Cambridge Launch UK AI Innovation Lab GSK to Acquire Nuvalent for $10.6b in Cash Merck Appoints Two Life Sciences Leadership Team Members AMD Commits up to £2b to Accelerate AI in UK » More News! » Submit your News! Upcoming Events EUROMAR 2026 Gothenburg (Göteborg) Gitex AI Europe 2026 Berlin Bay … 2027) bio:cap Investival 2027 Berlin (BioCap 2027) » More Events! » Submit your Event! Management Appointments Endress+Hauser Appoints Christian Mäder as Future CFO Orlando Oliveira Succeeds Dario Eklund as CEO of Santhera Merck Healthcare Appoints Head of Global Commercial Strategy Clara Sattler de Sousa e Brito Joins Merck (DE) from Philips Evotec Nominates Dieter Weinand as Supervisory Board Chair Santhera Appoints Marc Clausse as Chief Commercial Officer Coult … ion Appoints Fred Chereau as Chief Executive Officer » More News! » Submit your News! Financings & Acquisitions Merck KGaA to Acquire Bio-Techne for $11.3b (€9.9b) RQ Biotechnology Closes $115m (£85.5m) Series A Financing GSK to Acquire Nuvalent for $10.6b in Cash Ona Therapeutics Raises $86.6mSeries B to Advance ADCs Olix Pharma Secures KRW110b Investment from BOLD and Weiss T-Curx GmbH Acquires Pantherna Therapeutics GmbH Genovis Acquires KPL ApS for DKK30.5m Up … henoVista Biosciences to Expand in US Lauxera Capital Partners Closes Growth II Fund at €520m » More News! » Submit your News! Collaborations & Licensing Roche and Nurix: up to $2.3b Agreement for BTK Degrader Fusix Biotech & Recipharm Advance Oncolytic Virus Platform Lundbeck & Cradle Partner for AI-based Brain Disorder R&D Bonito Bi
Idaho Timber Corporation Acquired by Chartwell Investments/Leucadia National Corporation Skip to main content Hit enter to search or ESC to close Close Search search Menu About Our Team FAQs Careers HPC in the News Community Involvement Contact Us Global Network Services Mergers & Acquisitions Capital Raising Infrastructure Finance Fairness Opinions Financial Advisory Industries Healthcare Technology Industrials Business Services Financial Services Consumer Transactions Insights Industry Reports White Papers Press Releases Let’s Talk Details search Idaho Timber Corporation Acquired
Sohn Investment Conference 2025 — The Sohn Conference Foundation 0 Skip to Content Home About Conferences Philanthropy In the News Donate Open Menu Close Menu Home About Conferences Philanthropy In the News Donate Open Menu Close Menu Home About Conferences Philanthropy In the News Donate Save the Date May 12, 2026 JOIN US IN CELEBRATING 30 YEARS OF IMPACT May 14, 2025 Jazz at Lincoln Center’s Frederick P. Rose Hall Tickets About Venue Speakers FAQ Sponsors Agenda Watch 2025 videos Where Wall Street Unites to Fight Childhood Cancer The annual New York Sohn Investment Conference convenes … w York Sohn Investment Conference convenes some of the best and brightest hedge fund and alternative investors in the industry to share market insights, while raising funds in support of pediatric cancer and other research. IN PARTNERSHIP WITH Tickets General Admission $2,000 All-day access to Sohn programming, including Next Wave and the flagship Investment Conference, plus networking at lunch and the cocktail reception. CIO Ticket $5,000 Enhance your networking and on-site … itions Tim Harrington, Zac Yang 8:50 – 9:10 a.m. The Evolving Role of the Hedge Fund Research Analyst Tim Harrington, Thomas Li 9:10 – 9:35 a.m. Alt Data Mosaic - Consumer & Retail data driven signals and trends Gene Gallagher, Andrew Sprague, Evan Sohn 9:35 – 10:00 a.m. New Trade Era Crossroads: Global Giants vs. Local Makers in Retail/Consumer stocks Bryan Mistele, Zac Yang 10:15 a.m. – 12:00 p.m. Next Wave Sohn 10:15 AM | Introductory Remarks Harry Shillingford, Marex … tch Golden Rubric Capital Sachem Head Capital Management Seneca Capital Talpion Fund Management Media Partners Press Support by Contact Us For questions about the event or issues with registration, please email: [email protected] Tickets CIO Tickets are reserved for C-suite investment professionals. Sohn reserves the right to review all CIO Ticket purchases and reassign any registrant to General Admission if deemed necessary. All orders are non-refundable. The Sohn Confer … irector, East Rock Capital Farrah Kunwar Co-Chair, Next Wave Sohn Head of Hedge Fund Investments, Pragma Wealth Management Erik Serrano Berntsen Chief Executive Officer, Stable Diana Dieckman Head of Partnerships, SurgoCap Partners Home | About | Conferences | News | Philanthropy | Donate © 2026 THE SOHN CONFERENCE FOUNDATION | Legal Discl
LEUCADIA NATIONAL CORP (Form: 10-K, Received: 03/14/2005 15:08:58) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2004 or [_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number: 1-5721 LEUCADIA NATIONAL CORPORATION (Exact Name of Registrant as Specified in its Charter) New York 13-2615557 -------------------------- --------------- … a corporation engaged in real estate activities, Jefferies Partners Opportunity Fund II, LLC ("JPOF II") and EagleRock Capital Partners (QP), LP ("EagleRock"). Both JPOF II and EagleRock are engaged in investing and/or securities transactions activities. Corporate assets primarily consist of investments and cash and cash equivalents and corporate revenues primarily consist of investment income and securities gains and losses. Corporate assets, revenues, ov … certain available for sale securities and an equity investment in a non-public fund. The write down of the available for sale securities resulted from a decline in market value determined to be other than temporary. (d) Eliminates intersegment revenues billed from Network to Vyvx. However, the intersegment revenues are included in the calculation to determine segment profit from operations and income (loss) from continuing operations for each of Network and Vyvx. (e) For the … es, ("RBOCs") cable television companies, Internet service providers, application service providers, data storage service providers, managed network service providers, digital subscriber line service providers, long distance carriers, local service providers, utilities, governmental entities, educational institutions, financial institutions, international carriers and other communications services providers who desire high-capacity and high-speed products on a carri … re used in intrastate telecommunications services. Foreign laws and regulations apply to telecommunications that originate or terminate in a foreign country. Generally, the FCC and state commissions do not regulate Internet, video conferencing or certain data services, although the underlying telecommunications services components of such offerin
%PDF-1.4 %���� 9 0 obj > endobj xref 9 20 0000000016 00000 n 0000000876 00000 n 0000000696 00000 n 0000000953 00000 n 0000001131 00000 n 0000001252 00000 n 0000001765 00000 n 0000001928 00000 n 0000001962 00000 n 0000002201 00000 n 0000002277 00000 n 0000002929 00000 n 0000003590 00000 n 0000004222 00000 n 0000004857 00000 n 0000005488 00000 n 0000006144 00000 n 0000006812 00000 n 0000007375 00000 n 0000010044 00000 n trailer ]>> startxref 0 %%EOF 11 0 obj >stream x�b```"V�z^�ʰ!ǃ�'�E\�>00p004��� 30(1�p2��~hd`8˴(K�(LuR�ڣ*E)o^�b�E:�4[��U endstream endobj 10 0 obj > endobj 12
Leucadia National, Jefferies Agree To $3.6 Billion Merger - Hart Energy Skip to main content Open main menu Home Newsletters Latest Issue Return to homepage Return to homepage Upstream Energy Market Transactions Shale Plays Acquisitions and Divestitures (A&D) Technology & Innovation Alternative Energies Events Acquisitions and Divestitures Leucadia National, Jefferies Agree To $3.6 Billion Merger Gift Article Share Expand SK By Susan Klann, Hart Energy November 12, 2012 11:00 AM CST Featured Stories VIDEO EXCLUSIVE Acquisitions and Divestitures (A&D) NSAI CEO: Beyond Tier 1, There’
Leucadia Technologies, Inc. | Intellectual Property & Industry Research Alliances Skip to main content | Office of the Vice Chancellor for Research Toggle navigation Intellectual Property & Industry Research Alliances Search Terms Submit Search About About Our Office Our Impact Our Team Diversity and Equity Socially Responsible Licensing Startups Launched All Advanced Materials Agriculture BSAC-Affiliated Startup Communications, Information Technology, and Data Processing Electronic Systems and Components Energy Environment Medical Devices Medical Diagnostics Medical Therapeutics Resea
XML 139 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8 Leucadia Merger and Related Transactions 12 Months Ended Nov. 30, 2013 Business Combinations [Abstract]   Leucadia Merger and Related Transactions Note 4. Leucadia Merger and Related Transactions Merger Transaction On March 1, 2013, Jefferies Group LLC completed a merger transaction with Leucadia and became a wholly-owned subsidiary of Leucadia as described in Note 1 Organization and Basis of Presentation. Each share of Jefferies Group Inc.’s common stock outstanding was converted into common shares of Leucadia at an Exchange Ratio … roup, Inc. common stock was converted at the Exchange Ratio, into an equivalent award of shares of Leucadia, with all such awards for Leucadia shares subject to the same terms and conditions, including, without limitation, vesting and, in the case of performance-based restricted stock units, performance being measured at existing targets. Leucadia did not assume or guarantee any of our outstanding debt securities, but our 3.875% Convertible senior Debentures due 2029 with an … of the pre-combination service performed to the original service period of the award. (5) The fair value of Jefferies shares owned by Leucadia was based upon a price of $21.72, the closing price of Jefferies common stock at February 28, 2013.   Assets acquired (1):    Cash and cash equivalents      $ 3,017,958      Cash and securities segregated      3,728,742      Financial instru
New video from Undoing Aging... - Lifespan Research Institute Facebook Log In Lifespan Research Institute's Post Lifespan Research Institute July 18, 2018 · Shared with Public New video from Undoing Aging 2018: Doug Ethell, Founder and CEO of Leucadia Therapeutics, presenting: Alzheimer's Disease Begins as a Fixable Plumbing Problem. http://www.undoing-aging.org/.../doug-ethell-presenting... Btw: the facebook event page for Undoing Aging 2019 is already up fb.com/events/2044104465916196/ ____ #undoingaging #sens #foreverhealthy All reactions: 27 3 comments 11 shares Like Comment Most
🌟 Welcoming more Presenting Companies to MedTech World Middle East These industry leaders bring sharp perspectives, hands-on expertise, and real-world solutions to the global MedTech ecosystem: Mary McGovern CEO, Adtec Healthcare Limited Douglas Ethell Founder & CEO, Leucadia Therapeutics Padam Kafle CEO, vCodes Software Solutions LLC 💬 Start connecting 1:1 before the event Attendees can pre-book exclusive 1:1 meeting with these presenting companies via the MedTech World Match platform, no chaos, just focused conversations across both conference days. Join Now: https://eu1.hubs.ly/H0rgQQ
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
I feel energized after my session at the Longevity Investors Conference 2025 in Gstaad, where I joined the panel on “Navigating Biotech Investments: Risks and Rewards.” 🔥 We had a good discussion… | Garri Zmudze LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at an … y field move forward. And if you’d like to talk more about our new $120 million Fund II at LongeVC, come say hi while you’re here! 🤝 123 7 Comments Like Comment Share Copy LinkedIn Facebook X Doug Ethell 9mo Report this comment Sorry to have missed Gstaad this year! Methuselah Foundation , specifically Dave Gobel, was the first money into Leucadia Therapeutics. Ten years ago, I was a Professor with a new way to approach Alzheimer’s disease that NIH was never going to fund be
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Leucadia National Corporation - Page 9 - The New York Times Skip to content Skip to site index Leucadia National Corporation Today’s Paper Supported by SKIP ADVERTISEMENT Business Leucadia National Corporation Latest Search Search Clear this text input Morning Agenda: Jefferies, Small and Emboldened The investment bank took federal bailout money and is not hemmed in by the restrictions imposed on banks that did. By Amie Tsang Jefferies Reports $166.7 Million Loss in Quarter “We are humbled,” Richard Handler, the investment bank’s chief executive, said of the quarter, which was hurt by rocky ma … en DealBook Richard Handler of Leucadia to Join Board of Ex-SAC Executive’s New Fund Richard Handler is joining the board of Folger Hill Asset Management, which was started by Solomon Kumin and Leucadia National. By William Alden DealBook Ex-SAC Executive, Solomon Kumin, Strikes Out on His Own A former top executive for Steven A. Cohen is testing whether a person needs experience as a trader to raise big dollars for a hedge fund. By Matthew Goldstein DealBook Handler, Leucadi … binger The share sale is the latest in a series of moves by the embattled hedge fund billionaire Philip A. Falcone to focus on the Harbinger Group after reaching an $18 million settlement with the S.E.C. By Alexandra Stevenson The 30-Minute Interview Hugh R. Frater Mr. Frater is the chief executive of Berkadia Commercial Mortgage, a joint venture of Berkshire Hathaway and the Leucadia National Corporation. By Vivian Marino DealBook Chief of the Jefferies Group Earned $19 Mill … vestment trust as it prepares to take ownership of Rockefeller Center. Gotham's proposal, which has the support of several of the trust's other large shareholders, would use a rights offering to raise at least $105 million and combine that with a senior loan of at least $350 million to replace some of the trust's high-cost debt and give it the financial wherewithal to operate the property. By Stephanie Strom Block to Rockefeller Center Deal Is Seen A sufficient number of shar … rectors of National Intergroup Inc. said today that they have rejected a merger proposal from the Leucadia National Corporation because the bid is highly conditional and because a sale at this time would not be appropriate. Leucadia, a life insurance and consumer finance company and the largest shareholder in Intergroup, said it was disappointed.
Leucadia and FXCM sign MoU to deepen and extend partnership | LeapRate | Online Trading Industry News, Broker Intelligence & Fintech Analysis Forex Retail FX Institutional FX Brokers Education Regulation Platforms white label brokerage Exchanges Economic Calender People Interview Experts Markets Market News Live Market News Crypto Crypto Platforms Blockchain ICO Crypto Licensing Crypto Exchanges Crypto Legal Technology Fintech RegTech Paytech Platforms Regulation Fines Fraud Directory Brokers Prop Firms & Futures Trading Platforms Brokerage Software Legal Connectivity Marketing Liquidi … Series H, Valuation Climbs to $11 Billion By Leaprate Staff Robinhood Ventures Fund Invests $25 million in Design Platform Canva By Sam Boughedda SBI Holdings to Acquire Crypto Exchange Bitbank for JPY 46.7 billion By Leaprate Staff The AI front opens in the US-China decoupling, and the bill lands on Chinese assets By Charlotte Vaughan Brokers weigh BABA single-stock CFD risk as Anthropic alleges record Claude data theft By Charlotte Vaughan Leave a Reply Cancel reply You mu
Emerging Leader: Ryan Rodriguez, Leucadia Wastewater District | California Water Environment Association × --> My Profile LOG IN --> --> JOIN US Membership CWEA Membership CWEA Community Manage Your Membership Member Directory My Account COMMITTEES Local Sections Connections and Networking View All Central San Joaquin Colorado River Basin Desert & Mountain Golden Empire Los Angeles Monterey Bay North Coast North Sacramento Valley Northern San Joaquin Redwood Empire Sacramento Area San Diego San Francisco Santa Ana River Basin Santa Clara Valley Sierra Tri Counties We empower wastewater … rds For Students Scholarships Student Design Competition Stockholm Junior Water Prize Process Overview Apply Timeline Judges Login Plaque Ordering Awards View All Collection Systems Community Engagement Engineering and Research Laboratory Leadership (Plant of the Year, Supervisor, Emerging Leader) links Operations and Maintenance Pretreatment Safety Young Professionals Member Awards (5S, Quarter Century) Photo Contest WEF Honors AWARDS HOME WINNERS GALLERY Careers PROFILES Ve … mental Compliance Inspector Laboratory Analyst Mechanical Technologist OVERVIEW Apply Renewal Process Testing Options Certification Policies Candidate Materials Certification Registry Code of Ethics CERTIFICATION HOME EDUCATION & CREDITS MANAGE YOUR CERTIFICATION Home News Emerging Leader: Ryan Rodriguez, Leucadia Wastewater District Emerging Leader: Ryan Rodriguez, Leucadia Wastewater District Emerging Leaders , Members in the News Ryan Rodriguez, Field Technician III, Leuca
Skip to main content Ratings Sectors Insights Events Subscriptions About Us Contact Us About About Us Contact Us Careers Media Relations Feedback Regulatory Regulatory Affairs Criteria Code of Conduct & Ethics Privacy Policy Report an Issue / Whistleblowing Product Rating Actions Coverage Research & Analytics Products & Tools Rating Performance Region Europe North America Africa Asia Latin America Middle East Fitch Group Fitch Group Fitch Ratings Fitch Solutions Fitch Bohua Fitch Learning Owned by Hearst Copyright © 2026 Fitch Ratings, Inc., Fitch Solutions, Inc. and their subsidia
Leucadia Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 08 May 2025 Leucadia Therapeutics, Inc. Startups | Holding Company | 2015 | California, United States | 10-50 | www.leucadiatx.com Startups | Holding Company | 2015 | California, United States | 10-50 | www.leucadiatx.com Last update 08 May 2025 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Related 100 Clinical Results associated with Leucadia Therapeutics, Inc. Login to view more dat … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data
Leucadia Therapeutics: Towards the Prevention of Alzheimer’s Disease – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » Decem … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Doug Ethell - Founder, Chairman & CEO at Leucadia Therapeutics Inc | The Org Platform Enrich Pricing Log in Sign up Leucadia Therapeutics Inc Doug Ethell Unverified Doug Ethell Founder, Chairman & CEO Contact Dr. Ethell discovered an aging mechanism that allows Alzheimer’s disease pathology to begin. He received a PhD in Neuroscience from the University of British Columbia, in Vancouver, was a Human Frontiers of Science Long-term Fellow at the Max Planck Inst for Psychiatry in Germany, and was a Research Associate at the Scripps Research Institute in La Jolla, CA. He ran Alzheimer’s
Treating Alzheimer's disease, Leucadia Therapeutics, & Heath with Dr. Doug Ethell - 176 | Doug Ethell LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in,
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
CEA-025 Sponsorship Policy | Clean Energy Alliance Skip to content Sign Up for Email Updates Solicitations Future Member Agencies Job Opportunities FAQs Search for: About Background 2025-27 Strategic Plan What is CEA? How It Works Benefits FAQs Our Member Agencies Board of Directors Our Staff Job Opportunities Community Advisory Committee CEA News Connect With CEA on Social Media Meetings & Agendas Agendas & Minutes View Meeting Recordings Your Options Clean Impact Clean Impact Plus Green Impact Become a Green Impact Champion Solar Impact – Solar Billing Plan Personal Impact – Net En
EX-2.1 2 d438735dex21.htm AGREEMENT AND PLAN OF MERGER Agreement and Plan of Merger Exhibit 2.1 AGREEMENT AND PLAN OF MERGER Among LEUCADIA NATIONAL CORPORATION, LIMESTONE MERGER SUB, LLC, JEFFERIES GROUP, INC. JSP HOLDINGS, INC. and JASPER MERGER SUB, INC. Dated as of November 11, 2012 TABLE OF CONTENTS Page ARTICLE I THE TRANSACTIONS 2 Section 1.1 The Mergers and the LLC Conversion 2 Section 1.2 Closing 2 &nbs … 5(d) Agreement Preamble Antitrust Law Section 8.15(e) Award Section 2.2(h) Book-Entry Shares Section 1.4(a) Business Day Section 8.15(f) Cancelled Shares Section 2.1(d) Certificate of Amendment Section 5.19 Certificate of Conversion Section 1.3(b) Certificates Section 1.4(a) Closing Section 1.2 Closing Date Section 1.2 Code   … (c) Conversion Effective Time Section 1.3(b) Converted Stock-Based Award Section 2.2(h) Copyrights Section 3.15(a) Crimson Section 8.15(h) Debentures Section 5.14 Delaware Filings Section 1.3(c) DGCL Section 1.1(a) Dissenting Shares Section 2.1(f) DLLCA Section 1.1(b) DOL Section 8.15(i) End Date Section 7.1(b) Environmental Law … nbsp; Section 8.15(l) Exchange Agent Section 2.3(a) Exchange Fund Section 2.3(a) (iv) Term Section Excess Leucadia Common Stock Section 2.2(f)(i) Excess Shares Section 2.2(g)(ii) First Effective Time Section 1.3(a) First Certificate of Merger Section 1.3(a) First Merger Section 1.1(a) First Merger Agreement Section 1.1(a) Form S–4 & … Preamble Jefferies Approvals Section 3.3(b) Jefferies Award Plans Section 2.2(h) Jefferies Benefit Plans Section 8.15(r) Jefferies Board of Directors Recitals Jefferies Bylaws Section 3.1(c) Jefferies Charter Section 3.1(c) Jefferies Converted LLC &nb
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Leucadia Asset Management Fund Manager Profile | Preqin Skip to main content Products Our products Preqin Pro Alternative assets data platform Private Markets Research Industry research Term Intelligence Benchmark LPA terms Preqin Benchmarks Industry's leading performance data Preqin Sustainability ESG data and insights Company Intelligence Companies & deals data Enterprise Data Solutions Flexible data delivery solutions Transaction Intelligence A $5.4tn transaction repository Client stories What our clients say Quick Links Our data Asset classes we cover Create a free account Newslet … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data Contact us Insights+ Private markets research Homepage Browse reports Search Search the research library Webinar recordings Join conversations with our analysts Meet the analysts Meet the team behind the reports Learn more Learn more about Private Markets Resear … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Insights+ Homepage Search Webinar recordings Meet the analysts Learn more News & content Homepage Events Free Benchmarks Data coverage map Preqin Profiles Preqin Academy Compensation calculator About Who we are Our corporate responsibility Partners Press hub Careers Contact us QuickLinks Our data Asset classes we cover Create a free account Newslett … ed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers. Request demo Leucadia Asset Management — overview Type Fund Manager Location New York, NY, US Alternative Asset Class HF PE Established 2013 Firm Ownership Independent Firm Investment Team Staff Total Staff 124 About Leucadia Asset Management (LAM) is a U.S based fund manager that invests in private equity and hedge fu … demo to see more Leucadia Asset Management - private capital funds managed (1) Fund Name Vintage Strategy Status Fund Structure Closed Size (MN) Target Size (MN) Primary Region Focus Venture (General) Closed Commingled North America Showing 1 of 1 private capital fund managed by Leucadia Asset Management Request a demo to see more Performance tr
Leucadia Therapeutics - BioPharmGuy About Directory Promoted Listings Purchase Data Drug Pipelines Data Licensing Weekly Update Newsletter Contact Leucadia Therapeutics Founded 2015; Website Categories ( key ): IM Locations: HQ: Riverside, CA - Medical device for Alzheimer's ---------------------------------------- If you believe any of this information is incorrect, please let us know . If you would like in depth information on the active companies in our directory, please check out our data purchase page to learn more about the data fields we have and how the purchasing process works. We are
News — Leucadia Therapeutics Home Science Story About Us News Contact Home Science Story About Us News Contact News Media coverage of Leucadia’s revolutionary approach Leucadia Therapeutics has attracted attention from media outlets focused on aging and longevity. But we are particularly proud that our research is featured in “ Life Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love ,” a book by Tony Robbins, Peter Diamandis and Robert Hariri. The book explores medical innovations that promise to lengthen our lives and im … Company's Founding Global Chief Medical Officer READ PR Newswire: Former Global Fund Manager Joins Leucadia Therapeutics as Company's First CFO READ TPMG : “Alzheimer’s Researchers Release Free Apps to Track Memory and Cognition.” Read Leucadia TherapeuticS Home | Story | Science | About Us | Contact | © Copyright 2022 Leucadia. All rights reserved | All rights reserved | Legal Notice | Privacy Policy | Legal Notice Leucadia Therapeutics' web site is provided as a serv … ich can be accessed via our website at www.leucadiatx.com or through our mobile application. The terms “we,” “us,” and “our” refer to the Company. “You” refers to you, as a user of Service. I. CONSENT By accessing our Service, you accept our Privacy Policy and Terms of Use, and you consent to our collection, storage, use and disclosure of your personal information as described in this Privacy Policy. In addition, by using our Service, or services across partnered and unaffili … we may collect, referring/exit pages and URLs, platform types, preferences you submit and preferences that are generated based on the data you submit and number of clicks. “Personal Information” includes information that can be used to personally identify you, such as your name, address and email address. In addition, we may also track information provided to us by your browser or by our mobile application when you view or use the Service, such as the website you came from ( … on collected by us through the Service. Therefore, this Privacy Policy does not apply to your use of a third-party website accessed by selecting a link via our Service. To the extent that you access or use the Service through or on another website or application, then the privacy policy of that other website or application will apply to your acce
LAM ESG Policy - Leucadia Asset Management Asset Managers Investors Investment Offerings Management Team News Insights Contact Us LAM ESG Policy Leucadia is aware of the impact that a global asset management business may have on society and the environment. Leucadia believes that environmental, social and governance considerations should be integral to how it manages its business operations, in partnership and coordination with the broader business operations within Jefferies. Further, the broader Jefferies group has numerous ESG-related initiatives and principles which benefit Leucadia-affili
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
EX-10.2 5 tv509801_ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 LEUCADIA NATIONAL CORPORATION 316 Park Avenue South/New York, New York 10010-3007 / 212-400-1900, Fax 212 698 4869 April 4, 2006 Hard Rock Hotel Licensing, Inc Rank America, Inc c/o Mr. Michael Soll 6100 Old Park Lane Orlando, FL 32835 Ladies and Gentlemen: Leucadia National Corporation (" Leucadia "), through a subsidiary thereof, and Lawrence S. Hershfield, a member of Ranch Capital (" Ranch "), desire to acquire one-hundred percent (100%) of the equity interest of AA Capital … acquire one-hundred percent (100%) of the equity interest of AA Capital Equity Fund, L.P., a Delaware limited partnership (" AA Capital ") and AA Capital Biloxi Co-Investment Fund, L.P., a Delaware limited partnership (" AA Investment ", with AA Investment and AA Capital, together, " AA ") in Premier Entertainment Biloxi LLC (" Premier "), such interests consisting of (i) one-hundred percent (100*) of the issued and outstanding Class A
Fuchsia 'Miss Leucadia' | /RHS Home Become a member Menu Search Membership Become a member Home Menu Search Get involved Gardening Shows Gardens Learn Science Shop About My RHS Membership Become a member Home My RHS Get involved with the RHS Back Take action Back Get involved with RHS Horticulture Matters Wild About Gardens National Gardening Week Schools Volunteer Communities Back Community gardening Britain in Bloom It's Your Neighbourhood Community Outreach Campaign for School Gardening Affiliated Societies Find a local gardening group Join the RHS Back Individual & Joint membership Gif
Ira Pastor - Diagnosing, Treating & Curing Alzheimer's -... Facebook Log In Ira Pastor's Post Ira Pastor February 27, 2023 · Shared with Public Diagnosing, Treating & Curing Alzheimer's - Dr. Doug Ethell - Founder & CEO, Leucadia Therapeutics, joins me on Progress, Potential, And Possibilities Methuselah Foundation Dane Gobel Florina Gobel Aubrey de Grey #Alzheimers #Dementia #CerebrospinalFluid #CSF #Neurology #CNS #MedicalDevices #Longevity #Aging #Amyloid #Amyloidosis youtube.com Dr. Doug Ethell - Founder & CEO, Leucadia Therapeutics - Diagnosing, Treating &am
Methuselah Foundation Funds Leucadia Therapeutics to Work on a New Approach to Alzheimer’s Therapy – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Leucadia Asset Management LLC H-1B & PERM Sponsorship Data | Visa Bulletin U.S. Immigration Data Priority dates, work visas, and labor market data Visa Bulletin Salaries Roles Employers FAQ About Contact Support Leucadia Asset Management LLC H-1B & Green Card Sponsorship Data Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary Records Search for another employer Years of Data Last 3 Years Last 5 Years Last 10 Years All Available Years Visa Program All Programs H-1B Only Green Card Only 0 Total Filings 2021-Pr
Doug Ethell, Leucadia Therapeutics - Alzheimer's Diagnostic And Therapeutic Solutions | LSI Europe '25 - Life Science Intelligence USA Europe Asia Compass AI Login Medtech Pro Login Events Featured Our Next Event Register for LSI Asia ‘26 Who's Attending? See LSI Asia '26 Attendee List Events Overview See Who's Attending Who Attends Why Present Upcoming Summits LSI Asia ‘26 LSI Europe '26 LSI USA ‘27 Past Summits LSI Asia ‘25 LSI Europe ‘25 LSI USA ‘26 Archives Insights Featured Just Launched Compass AI New Report Emerging Innovators Report Compass Al Emerging Innovators Report Marke … Our our third one is Ned Shadic. He's um an MBA, Harvard MBA, former hedge fund manager, ran four billion dollars for Putinham Investments before it was acquired. Then he retired and he's sort of working on a fractional basis with us. But uh that's sort of us. I'm here for the rest of the conference. If you'd like to chat with me, I'm available. Love to chat with you. Thank Share Facebook X WhatsApp LinkedIn Copy Link Doug Ethell, Leucadia Therap … Our our third one is Ned Shadic. He's um an MBA, Harvard MBA, former hedge fund manager, ran four billion dollars for Putinham Investments before it was acquired. Then he retired and he's sort of working on a fractional basis with us. But uh that's sort of us. I'm here for the rest of the conference. If you'd like to chat with me, I'm available. Love to chat with you. Thank Similar Videos Signature Series with Harry Stebbings, Founder of 20VC | L
Leucadia Therapeutics | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Leucadia Therapeutics Leucadia Therapeutics is dedicated to developing innovative treatments for Alzheimer's disease, focusing on restoring cerebrospinal fluid flow to prevent and cure the disease. Their mission is to end Alzheimer's through novel, non-invasive therapies and diagnostic tools, aiming to diagnose early, prevent, and reverse the disease. Industries big-data biotechnology health-care health-diagnostics life-science medical-device ne
Undoing Aging: Doug Ethell’s Presentation on the Leucadia Therapeutics Approach to Treating Alzheimer’s Disease – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives … ngle one. That is what I call a systematic error. So a few years ago I began to apply Occam's razor to this, looking for a more simplistic solution. Is there something basic that we are missing, something that can account for the age-dependent incidence of the disease? Something that accounts for the higher risk for people who have traumatic head injuries, and the near certainty that people with specific mutations will develop the disease at an early age, just like Auguste De … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room 
Musicbed You need to enable JavaScript to run this app. tag. To begin the development, run `npm start` or `yarn start`. To create a production bundle, use `npm run build` or `yarn build`. -->
Leucadia is working to erase Alzheimer's Disease Home Science Story About Us News Contact Home Science Story About Us News Contact HEARTBREAK IS… mourning THE LOSS OF someone while they are still alive Many of us know someone with Alzheimer’s disease, the most common form of dementia. Over $30 billion has been spent to develop a drug-based cure for it. So far, nothing works. We are determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment. Our first mission is to test it by reversing mild cognitive impairment associated with Alzheimer’s disease. Afterward … ich can be accessed via our website at www.leucadiatx.com or through our mobile application. The terms “we,” “us,” and “our” refer to the Company. “You” refers to you, as a user of Service. I. CONSENT By accessing our Service, you accept our Privacy Policy and Terms of Use, and you consent to our collection, storage, use and disclosure of your personal information as described in this Privacy Policy. In addition, by using our Service, or services across partnered and unaffili … we may collect, referring/exit pages and URLs, platform types, preferences you submit and preferences that are generated based on the data you submit and number of clicks. “Personal Information” includes information that can be used to personally identify you, such as your name, address and email address. In addition, we may also track information provided to us by your browser or by our mobile application when you view or use the Service, such as the website you came from ( … on collected by us through the Service. Therefore, this Privacy Policy does not apply to your use of a third-party website accessed by selecting a link via our Service. To the extent that you access or use the Service through or on another website or application, then the privacy policy of that other website or application will apply to your access or use of that site or application. We encourage our users to read the privacy statements of other websites before proceeding to
Home - Leucadia Asset Management Asset Managers Investors Investment Offerings Management Team News Insights Contact Us Strategic Alignment Across Leucadia Asset Management At the foundation of the platform is a focus on strategic alignment across LAM, its asset managers and its institutional investors. Strategic Alignment Across Leucadia Asset Management At the foundation of the platform is a focus on strategic alignment across LAM, its asset managers and its institutional investors. Strategic Alignment Across Affiliated Asset Managers LAM provides its affiliated asset managers with access to
About Us — Leucadia Therapeutics Home Science Story About Us News Contact Home Science Story About Us News Contact About Us We take a different approach to Alzheimer’s disease Researchers have spent more than $30 billion on failed clinical trials for medicines to treat Alzheimer’s disease. We are committed to curing it. Our approach has attracted the attention of thought leaders and trailblazers in medicine and business. Together, we are focused on developing the tools that enable medicine to diagnose the disease before symptoms begin to erode a person’s quality of life and deploy … alifornia. Dr. Siddiqi completed his doctorate at Oxford University on a Rhodes Scholarship, his neurosurgery residency at the University of Western Ontario, and a fellowship in skull base and vascular surgery at the University of Arkansas Center for Medical Sciences, Little Rock, AK. He is chair of Neurosurgery/Surgery at the California University of Sciences and Medicine Medical School. Edward (Ned) T. Shadek, Jr., MBA, CPA CHIEF FINANCIAL OFFI … was a founder of Shaylor Capital, a $20 million boutique small cap value hedge fund; head of Amundi Pioneer’s Small/Mid Cap Value effort and lead manager of its Pioneer Value Fund, and principal of Sagehen Investments. He earned an MBA from Harvard and is a certified public accountant. Sergio Ruiz BOARD OF DIRECTORS Co-founder and managing director of Methuselah Funds and chief operating officer of Methuselah Foundation, Mr. Ruiz has dedicated himself to length … geons and the Western Neurosurgical Society. Dr. Lee completed his Neurosurgery residency at the University of Oxford and Edinburgh, UK. He completed further advanced training in Skull Base-Cerebrovascular surgery and Radiosurgery through fellowships at Stanford University. Founding Investors Leucadia TherapeuticS Home | Story | Science | About Us | Contact | © Copyright 2022 Leucadia. All rights reserved | All rights res … ich can be accessed via our website at www.leucadiatx.com or through our mobile application. The terms “we,” “us,” and “our” refer to the Company. “You” refers to you, as a user of Service. I. CONSENT By accessing our Service, you accept our Privacy Policy and Terms of Use, and you consent to our collection, storage, use and disclosure of your pe
Leucadia Therapeutics Inc - Leadership Team | The Org Platform Enrich Pricing Log in Sign up Leucadia Therapeutics Inc Teams Leadership Team Unverified Leadership Team 3 people · 0 jobs Leucadia Therapeutics Inc's Leadership Team includes Doug Ethell and 2 others. People ( 3 ) Doug Ethell Founder, Chairman & CEO Edward T. Shadek CFO Javed Siddiqi Director & Chied Medical Officer Jobs ( 0 ) No jobs in this team Other teams View all teams No other teams Company About Contact Blog Business Solutions Trust Pricing Directory Companies People Features Employer Branding Professional Ne
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Leucadia Therapeutics Inc - HQ | The Org Platform Enrich Pricing Log in Sign up Leucadia Therapeutics Inc Offices HQ Unverified HQ 0 people · 0 jobs Leucadia Therapeutics Inc's headquarters in Riverside, CA, United States Office location People ( 0 ) No people in this office Jobs ( 0 ) No jobs in this office Other offices View all offices No other offices Company About Contact Blog Business Solutions Trust Pricing Directory Companies People Features Employer Branding Professional Networking Job Discovery Social © 2026 Orgio, Inc. Terms Privacy Do not sell my info
Science — Leucadia Therapeutics Home Science Story About Us News Contact Home Science Story About Us News Contact Science A New Vision For decades, most Alzheimer’s researchers have blamed the disease on plaques and tangles in the brain. They’re wrong. LEUCADIA'S research shows that plaques and tangles are a side effect of a more serious underlying condition – the one that actually causes Alzheimer’s disease. The research also shows that a cure may soon be possible. Alzheimer’s disease is caused by a plumbing problem in the skull Alzheimer’s disease begins near the cribriform plat … ich can be accessed via our website at www.leucadiatx.com or through our mobile application. The terms “we,” “us,” and “our” refer to the Company. “You” refers to you, as a user of Service. I. CONSENT By accessing our Service, you accept our Privacy Policy and Terms of Use, and you consent to our collection, storage, use and disclosure of your personal information as described in this Privacy Policy. In addition, by using our Service, or services across partnered and unaffili … we may collect, referring/exit pages and URLs, platform types, preferences you submit and preferences that are generated based on the data you submit and number of clicks. “Personal Information” includes information that can be used to personally identify you, such as your name, address and email address. In addition, we may also track information provided to us by your browser or by our mobile application when you view or use the Service, such as the website you came from ( … on collected by us through the Service. Therefore, this Privacy Policy does not apply to your use of a third-party website accessed by selecting a link via our Service. To the extent that you access or use the Service through or on another website or application, then the privacy policy of that other website or application will apply to your access or use of that site or application. We encourage our users to read the privacy statements of other websites before proceeding to
Leucadia is working to erase Alzheimer's Disease Home Science Story About Us News Contact Home Science Story About Us News Contact HEARTBREAK IS… mourning THE LOSS OF someone while they are still alive Many of us know someone with Alzheimer’s disease, the most common form of dementia. Over $30 billion has been spent to develop a drug-based cure for it. So far, nothing works. We are determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment. Our first mission is to test it by reversing mild cognitive impairment associated with Alzheimer’s disease. Afterward … ich can be accessed via our website at www.leucadiatx.com or through our mobile application. The terms “we,” “us,” and “our” refer to the Company. “You” refers to you, as a user of Service. I. CONSENT By accessing our Service, you accept our Privacy Policy and Terms of Use, and you consent to our collection, storage, use and disclosure of your personal information as described in this Privacy Policy. In addition, by using our Service, or services across partnered and unaffili … we may collect, referring/exit pages and URLs, platform types, preferences you submit and preferences that are generated based on the data you submit and number of clicks. “Personal Information” includes information that can be used to personally identify you, such as your name, address and email address. In addition, we may also track information provided to us by your browser or by our mobile application when you view or use the Service, such as the website you came from ( … on collected by us through the Service. Therefore, this Privacy Policy does not apply to your use of a third-party website accessed by selecting a link via our Service. To the extent that you access or use the Service through or on another website or application, then the privacy policy of that other website or application will apply to your access or use of that site or application. We encourage our users to read the privacy statements of other websites before proceeding to
Prominent Neurosurgeon Joins Leucadia Therapeutics as Company's Founding Global Chief Medical Officer - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Ce … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Beach Prominent Neurosurgeon Joins Leucadia Therapeutics as Company’s Founding Global Chief Medical Officer August 22, 2022 | 3 min read Twitter LinkedIn Facebook Email Print Leucadia Therapeutics, a company working to cure Alzheimer’s disease, has hired a global chief medical officer practiced in skull base neu … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin